We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MICC:NYSEThe Magnum Ice Cream Company N.V. Analysis

Data as of 2026-05-24 - not real-time

$16.05

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The Magnum Ice Cream Company trades at a trailing P/E of 28.7 and a forward P/E of 12.5, while the discounted cash‑flow model values the stock at roughly $2.9 – indicating a substantial premium to intrinsic value. Recent news highlights a solid Q1 performance with +4.5% organic sales growth and renewed FY guidance, which helped lift the share price in the short run. Technicals are mixed: the 20‑day SMA (≈15.0) sits below the current price of $16.05, the MACD line is bullish (0.45 above signal), and RSI is at a moderate 59, but volume is trending down and volatility over the past 30 days is high at over 60%. The balance sheet is strained – a debt‑to‑equity ratio above 500 and net debt far exceeding cash raise concerns about financial flexibility. Despite operating in the defensive packaged‑foods sector, the company’s margins are thin (gross 34.6%, profit 3.7%) and revenue is declining year‑over‑year (‑4.1%). Overall, the stock shows short‑term price momentum but appears materially overvalued relative to fundamentals and carries elevated financial and market risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and price above short‑term SMA
  • Recent Q1 sales beat and positive earnings guidance
  • High valuation premium and decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential private‑equity interest could unlock value
  • Continued earnings pressure from thin margins
  • Elevated leverage limiting reinvestment capacity

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • DCF fair value far below market price
  • Debt‑to‑equity ratio > 500 indicating solvency risk
  • Stagnant growth and high volatility in a defensive sector

Key Metrics & Analysis

Financial Health

Revenue Growth-4.10%
Profit Margin3.70%
P/E Ratio28.7
ROE17.88%
ROA8.72%
Debt/Equity539.65
P/B Ratio13.6
Op. Cash Flow$483.0M
Free Cash Flow$365.6M

Technical Analysis

TrendNeutral
RSI59.7
Support$12.94
Resistance$17.03
MA 20$15.00
MA 50$14.70
MA 200$15.60
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$2.91
Target Price$17.53
Upside/Downside9.19%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.65
Volatility60.48%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.